Shares of Novavax slid 7.39% to $219.43 at 10:19 EST on Monday, after two successive sessions in a row of losses. NASDAQ Composite is rising 0.4% to $14,018.20, following the last session’s downward trend, This seems, up to now, a somewhat positive trend exchanging session today.
Novavax’s last close was $237.53, 51.16% below its 52-week high of $331.68.
Novavax’s sales growth is 8542.9% for the present quarter and 1971.3% for the next. The company’s growth estimates for the present quarter is a negative 356.9% and positive 930% for the next.
Year-on-year quarterly revenue growth grew by 3072.2%, now sitting on 475.6M for the twelve trailing months.
Novavax’s Stock Yearly Top and Bottom Value
Novavax’s stock is valued at $219.43 at 10:19 EST, way under its 52-week high of $331.68 and way above its 52-week low of $14.38.
Novavax’s Moving Average
Novavax’s value is higher than its 50-day moving average of $210.81 and way higher than its 200-day moving average of $149.03.
More news about Novavax.